Pharmaceutical Studies of Levothyroxine Sodium Hydrate Suppository Provided as a Hospital Preparation
2015 ◽
Vol 38
(4)
◽
pp. 625-628
◽
Yuhei Hamada
◽
Kazushi Masuda
◽
Masato Okubo
◽
Hiromitsu Nakasa
◽
Yuko Sekine
◽
...
2012 ◽
Vol 2
(10)
◽
pp. 1-2
2018 ◽
Vol 10
(4)
◽
pp. 2206-2212
◽
Hiroshi Okamoto
◽
Ko Onodera
◽
Rikiya Kamba
◽
Yusuke Taniyama
◽
Tadashi Sakurai
◽
...
2005 ◽
Vol &NA;
(1496)
◽
pp. 12
2021 ◽
Vol 1863
(1)
◽
pp. 207-207
2021 ◽
Vol 1844
(1)
◽
pp. 262-262
1992 ◽
Vol 152
(1)
◽
pp. 183
◽
1997 ◽
Vol 73
(6)
◽
pp. 617-622
◽
Megumi MATSUNO
◽
Motoi SOHMIYA
◽
Masateru NISHIKI
◽
Satoshi OHGUNI
◽
Yuzuru KATO
2021 ◽
Vol 1875
(1)
◽
pp. 195-195
New product intros [ADV-7103 (new combination), asparaginase Erwinia chrysanthemi, empagliflozin (new indication), MVC-COV-1901, ON-101, penpulimab, ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib tartrate (new indication), zimberelimab, ZyCoV-D]
2021 ◽
Vol 57
(11)
◽
pp. 699